| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910399A1 Stable pharmaceutical composition of bdnf |
| 04/28/1999 | EP0910381A1 Method for treating pain |
| 04/28/1999 | EP0910379A1 Plaster for the transdermal application of pergolide |
| 04/28/1999 | EP0910372A1 Pharmaceutical compositions containing mesembrine and related compounds |
| 04/28/1999 | EP0910356A1 Biphenylamido derivatives as melatonergic agents |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215400A Piperazine and piperidine compounds |
| 04/28/1999 | CN1215399A Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 04/28/1999 | CN1215396A Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215053A Pharmacologically active enantiomers and method for their preparation |
| 04/28/1999 | CN1215052A Pharmacollogically active enantiomers and method for their preparation |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5898066 Trophic factors for central nervous system regeneration |
| 04/27/1999 | US5897875 Treating painful muscular cramp conditions in abdominal cavity comprising administering a therapeutical amount of alpha, alpha-diphenylacetic acid-4(n-methyl-piperidyl)ester |
| 04/27/1999 | CA2097182C Method and device for treating tobacco addiction |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/23/1999 | CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
| 04/22/1999 | WO1999019483A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999019351A1 Novel npy family member |
| 04/22/1999 | WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 04/22/1999 | WO1999019325A1 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 04/22/1999 | WO1999019324A2 Antipsychotic substituted piperidine derivatives |
| 04/22/1999 | WO1999019323A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use |
| 04/22/1999 | WO1999019320A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | WO1999019317A1 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 04/22/1999 | WO1999019306A2 2,3-benzodiazepin-2-one derivatives, their preparation and their use as inhibitors of protein tyrosine kinases |
| 04/22/1999 | WO1999019305A2 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 04/22/1999 | WO1999019293A1 Novel aryloxy-alkyl-dialkylamines |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018976A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | WO1999018967A1 Analgesic compositions |
| 04/22/1999 | WO1999018966A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 04/22/1999 | WO1999018962A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | WO1999018941A2 Ih-MODULATORS |
| 04/22/1999 | WO1999018794A1 Method for treating alzheimer's disease |
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999013717B1 A delivery of arginine to cause beneficial effects |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1998052548A3 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
| 04/22/1999 | WO1998050383A8 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2306276A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | CA2306228A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2305499A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | CA2305277A1 Antipsychotic substituted piperidine derivatives |
| 04/22/1999 | CA2305262A1 Method for treating alzheimer's disease |
| 04/22/1999 | CA2305255A1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 04/22/1999 | CA2305180A1 Ih-modulators |
| 04/22/1999 | CA2304379A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909763A2 Colchicine derivatives and the therapeutical use thereof |
| 04/21/1999 | EP0909561A2 Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder |
| 04/21/1999 | EP0909559A2 Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament for treatment or prophylaxis of diseases of the central nervous system |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909184A2 Targeted drug delivery using sulfonamide derivatives |
| 04/21/1999 | EP0909171A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 04/21/1999 | EP0885217A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0882039A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0674660B1 Multifunctional neurotrophic factors |
| 04/21/1999 | EP0633261B1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/21/1999 | CN1214672A Dimethyl-substituted cyclohexane diene derivatives |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/21/1999 | CN1214245A Application of sinomenine in preparing analgesic |
| 04/20/1999 | US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists |
| 04/15/1999 | WO1999018432A1 Methods for screening drugs to predict tardive dyskinesia |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018123A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/15/1999 | WO1999018105A1 Dipyridoimidazolderivatives useful in treating central nervous system disorders |
| 04/15/1999 | WO1999018104A1 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders |
| 04/15/1999 | WO1999018091A1 Novel compounds useful as neuro-protective agents |
| 04/15/1999 | WO1999018084A1 Method and reagents for n-alkylating ureides |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999017806A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 04/15/1999 | WO1999017803A1 Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017779A1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 04/15/1999 | WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017772A1 5ht4 agonists and antagonists |
| 04/15/1999 | WO1999017771A1 Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine |
| 04/15/1999 | WO1999017755A2 Medicaments |
| 04/15/1999 | WO1999017751A1 Controlled release solid dosage forms of lithium carbonate |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017623A1 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects |
| 04/15/1999 | WO1999017612A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/15/1999 | WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 04/15/1999 | WO1999002142A3 Novel composition comprising an ssri and a beta-blocker |